For a change, I now think / suspect he actually had a cash position on — betting on a decline in CAPR stock.
He guessed wrong, on the clinical trial that the company was/is running — preposterously thinking that he understood more organic chemistry — in the form of cardiosphere-derived cells, or CDCs, which is an endogenous population of stromal cells derived from cells of healthy human hearts — than the company’s Johns Hopkins credentialed / Ph.D. leadership. Yep, he was wiped out — as the the stock leapt over 370 percent today (see at right) — on excellent interim trial results.
In a word, he looked… positively rekt.
And if you want to see him burping, incessantly — in a bout of panicked indigestion, this morning — here’s that live stream, from his YouTube channel.
He still has a baby to feed — and Christmas is almost here.
My best bet is that he is penniless — again.
We shall see.
But people who follow him, based on his supposed bio-science / pharma-science chops… are uniformly… idiots.
Onward, and out [yep, this is power-alley stuff]….